Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Rissmann

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Journal of Lipid Research|July 11, 2024
Guselkumab treatment normalizes the stratum corneum ceramide profile and alleviates barrier dysfunction in psoriasis: results of a randomized controlled trialJannik Rousel, Catherine Mergen, Menthe E Bergmans, et al.
British Journal of Clinical Pharmacology|July 28, 2025
Mild psoriasis as a suitable model for proof-of-mechanism in a phase 1B setting: Results from a double-blind placebo-controlled trial with guselkumabJannik Rousel, Menthe E Bergmans, Lisa J Bruijnincx, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2022
No effect of topical digoxin and furosemide for patients with actinic keratosisBertine W Huisman, Lauren E H Nené, Feeke L L Linders, et al.
Clinical and Translational Science|February 12, 2020
Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy VolunteersTessa Niemeyer-van der Kolk, Salma Assil, Thomas P Buters, et al.
JAAD International|February 3, 2026
Remote monitoring in chronic immune-mediated inflammatory diseases: A systematic review of active and passive approachesMariona Oliver, Jannik Rousel, Jan W Schoones, et al.
Inflammation|August 25, 2024
Extending the IMQ Model: Deep Characterization of the Human TLR7 Response for Early Drug DevelopmentJuliette A van den Noort, Salma Assil, Micha N Ronner, et al.
Clinical and Translational Science|August 7, 2023
Intradermal substance P as a challenge agent in healthy individualsWouter Ten Voorde, Chika Akinseye, Ismahaan Abdisalaam, et al.
Journal of the American Academy of Dermatology|June 13, 2026
AI-Powered Imaging for Objective Psoriasis Severity Assessment at Home: Feasibility and Reliability in a Randomized Clinical TrialMariona Oliver, Monika Molnarova, Menthe Bergmans, et al.
Experimental Dermatology|March 11, 2026
Clinical Validation of Imaging Biomarkers in Mycosis FungoidesSelinde S Wind, Elise S M Beljaards, Rianne Rijneveld, et al.
Experimental Dermatology|April 13, 2023
A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteersWouter Ten Voorde, Mahdi Saghari, Jiry Boltjes, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Journal of Lipid Research|July 11, 2024
Guselkumab treatment normalizes the stratum corneum ceramide profile and alleviates barrier dysfunction in psoriasis: results of a randomized controlled trialJannik Rousel, Catherine Mergen, Menthe E Bergmans, et al.
British Journal of Clinical Pharmacology|July 28, 2025
Mild psoriasis as a suitable model for proof-of-mechanism in a phase 1B setting: Results from a double-blind placebo-controlled trial with guselkumabJannik Rousel, Menthe E Bergmans, Lisa J Bruijnincx, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2022
No effect of topical digoxin and furosemide for patients with actinic keratosisBertine W Huisman, Lauren E H Nené, Feeke L L Linders, et al.
Clinical and Translational Science|February 12, 2020
Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy VolunteersTessa Niemeyer-van der Kolk, Salma Assil, Thomas P Buters, et al.
JAAD International|February 3, 2026
Remote monitoring in chronic immune-mediated inflammatory diseases: A systematic review of active and passive approachesMariona Oliver, Jannik Rousel, Jan W Schoones, et al.
Inflammation|August 25, 2024
Extending the IMQ Model: Deep Characterization of the Human TLR7 Response for Early Drug DevelopmentJuliette A van den Noort, Salma Assil, Micha N Ronner, et al.
Clinical and Translational Science|August 7, 2023
Intradermal substance P as a challenge agent in healthy individualsWouter Ten Voorde, Chika Akinseye, Ismahaan Abdisalaam, et al.
Journal of the American Academy of Dermatology|June 13, 2026
AI-Powered Imaging for Objective Psoriasis Severity Assessment at Home: Feasibility and Reliability in a Randomized Clinical TrialMariona Oliver, Monika Molnarova, Menthe Bergmans, et al.
Experimental Dermatology|March 11, 2026
Clinical Validation of Imaging Biomarkers in Mycosis FungoidesSelinde S Wind, Elise S M Beljaards, Rianne Rijneveld, et al.
Experimental Dermatology|April 13, 2023
A multimodal, comprehensive characterization of a cutaneous wound model in healthy volunteersWouter Ten Voorde, Mahdi Saghari, Jiry Boltjes, et al.
Pageof 10